Aging cell

The SASP factor IL-6 helps aging cells maintain themselves through an internal cGAS-STING-NFκB signaling pathway

Updated

Abstract

Inactivation of IL-6 in somatotrophic senescent cells transforms them into strongly tumorigenic in NOD/SCID mice.

  • Senescent cells produce a (SASP) that includes interleukin-6 (IL-6) with diverse effects.
  • IL-6 amplifies cellular senescence through an intracrine mechanism rather than through secretion or receptor interaction.
  • The intracellular IL-6 receptor engages with cytosolic DNA, activating the cGAS-STING pathway and NFκB, contributing to cell-autonomous senescence.
  • This pathway significantly influences tumor growth control in senescent cells.
  • Evidence of the intracrine senescent IL-6 pathway is found in three human cellular models of therapy-induced senescence.

Simplified

Key numbers

2 of 4 mice
Tumorigenicity Increase
Tumor formation in NOD/SCID mice after IL-6 knockout.
100%
SA-β-Gal Positive Cells
Percentage of SA-β-Gal positive cells in IL-6 knockout clones.

Full Text

What this is

  • This research investigates the role of interleukin-6 (IL-6) in cellular senescence, focusing on its intracellular signaling mechanisms.
  • IL-6, a key factor in the (), is shown to promote senescence through an intracrine pathway rather than through traditional receptor-mediated signaling.
  • The study reveals that IL-6 sustains senescent cells and influences tumor growth, suggesting potential therapeutic implications for targeting senescence in cancer.

Essence

  • IL-6 promotes cell-autonomous senescence through an intracrine mechanism involving cGAS-STING and NFκB pathways, independent of its membrane receptor. This pathway is crucial for maintaining senescence and regulating tumor growth.

Key takeaways

  • IL-6 induces senescence markers in pituitary tumor cells through an pathway. This signaling occurs without the need for IL-6 to be secreted or bind to its membrane receptor.
  • Inactivation of IL-6 in somatotrophic senescent cells leads to increased tumorigenicity in NOD/SCID mice. Reintroducing IL-6 restores senescence control, highlighting its role in tumor suppression.
  • The intracrine action of IL-6 is also observed in therapy-induced senescence models, such as glioblastoma and lung adenocarcinoma cells, indicating a broader relevance of this mechanism across different cancer types.

Caveats

  • The study primarily uses in vitro models and may not fully capture the complexity of IL-6 signaling in vivo. Further research is needed to validate these findings in clinical settings.
  • The specific cellular contexts and conditions under which IL-6 operates may vary, limiting the generalizability of the results across different tumor types and microenvironments.

Definitions

  • Senescence-Associated Secretory Phenotype (SASP): A collection of factors secreted by senescent cells that can influence neighboring cells and contribute to tumorigenesis.
  • Intracrine signaling: A form of signaling where a substance acts within the same cell that produces it, rather than being secreted and acting on neighboring cells.

Simplified

Funding

Competing interests

The authors declare no competing interests.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free